Oppenheimer Private Equity Investments oppenheim.de

Oppenheimer Private Equity Investments - Investments & Acquisitions

Show Real Data Oppenheimer Private Equity Investments Investments
See all Recent Investments
Date Company Round Amount Co-investors
2004-04-19Mast TherapeuticsUnattributed VC$15.38MAlpha Capital Partners, Anasazi Partners, BayStar Capital, Bristol Capital Advisors, BSI SA, BSI-New Biomedical Frontier, Carpe Diem Capital Management, Castle Creek Capital, Centrum Bank AG, Crestview Capital Funds, Enable Capital Management, Gamma Capital Partners, Greenwich Growth Fund, Heights Capital Management, JIBS Equities, Laddcap Value Advisors, LB Swiss Investment, North Sound Capital, OTAPE Investments, Platinum Management, ProMed Capital, Ritchie Capital Management, Rock Hill Investment Management, Saad Investments Company, Schroders, SDS Capital Partners, SF Capital Group, Stonestreet, TCMP3 Capital, Viking Asset Management, Whalehaven Capital, Xmark Asset Management, and Xmark Funds
2003-09-19Synovis Life TechnologiesUnattributed VC$39MAcqua Wellington Asset Management, Argonaut Capital Management Corporation, BayStar Capital, Bernay Box & Co., Bridgeway Capital Management, Downsview Capital, First Investors Management Company, Heights Capital Management, Highbridge Capital Management, Iroquois Capital Group, Langley Capital, LibertyView Capital Management, Lionsgate, North Sound Capital, Phoenix Partners, ProMed Capital, Silver Oak Investments, and Tacony Investment Partnership
2001-04-05BuildOnlineSeries C$15MBancBoston Capital, Delta Private Equity Partners, ETF Group, Goldman Sachs, Upfront Ventures, and VPSA
2001-03-09Blaze Network ProductsSeries B$40MCrown Advisors International, Dawntreader Ventures, Dynafund Ventures, EastWest VentureGroup, Foxconn Technology Company, GTG Ventures, Intel Capital, Kalkhoven Pettit Levin & Johnson Ventures, Motorola Solutions Venture Capital, OppenheimerFunds, Pyramid Technology Ventures, Sands Brothers Venture Capital, Vanguard Ventures, and Wasserstein & Co.
2000-10-23SemagixSeries C$5M
See all 11 investments